Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer: Gynecologic Oncology

A. Redondo, N. Colombo, M. McCormack, L. Dreosti, A. Nogueira-Rodrigues, G. Scambia, D. Lorusso, F. Joly, M. Schenker, P. Ruff, M. Estevez-Diz, N. Irahara, M. Donica, A. Gonzalez-Martín

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer: Gynecologic Oncology'. Together they form a unique fingerprint.

Medicine & Life Sciences